...
首页> 外文期刊>Journal of Medicinal Chemistry >Selective inhibitors of bacterial t-RNA-(N~1G37) methyltransferase (TrmD) that demonstrate novel ordering of the lid domain
【24h】

Selective inhibitors of bacterial t-RNA-(N~1G37) methyltransferase (TrmD) that demonstrate novel ordering of the lid domain

机译:细菌t-RNA-(N〜1G37)甲基转移酶(TrmD)的选择性抑制剂表现出盖结构域的新顺序

获取原文
获取原文并翻译 | 示例

摘要

The tRNA-(N~1G37) methyltransferase (TrmD) is essential for growth and highly conserved in both Gram-positive and Gram-negative bacterial pathogens. Additionally, TrmD is very distinct from its human orthologue TRM5 and thus is a suitable target for the design of novel antibacterials. Screening of a collection of compound fragments using Haemophilus influenzae TrmD identified inhibitory, fused thieno-pyrimidones that were competitive with S-adenosylmethionine (SAM), the physiological methyl donor substrate. Guided by X-ray cocrystal structures, fragment 1 was elaborated into a nanomolar inhibitor of a broad range of Gram-negative TrmD isozymes. These compounds demonstrated no activity against representative human SAM utilizing enzymes, PRMT1 and SET7/9. This is the first report of selective, nanomolar inhibitors of TrmD with demonstrated ability to order the TrmD lid in the absence of tRNA.
机译:tRNA-(N〜1G37)甲基转移酶(TrmD)对于生长至关重要,并且在革兰氏阳性和革兰氏阴性细菌病原体中均高度保守。此外,TrmD与人类直向同源物TRM5非常不同,因此是设计新型抗菌药物的合适靶标。使用流感嗜血杆菌TrmD筛选化合物片段的集合,确定了与生理性甲基供体底物S-腺苷甲硫氨酸(SAM)竞争的抑制性稠合噻吩并嘧啶酮。在X射线共晶结构的指导下,将片段1精制为多种革兰氏阴性TrmD同工酶的纳摩尔抑制剂。这些化合物对利用酶PRMT1和SET7 / 9的代表性人SAM无活性。这是TrmD选择性纳摩尔抑制剂的首次报道,该抑制剂具有在不存在tRNA的情况下订购TrmD盖子的能力。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号